Abaxis (NASDAQ:ABAX) and Midwest Energy Emissions (OTCMKTS:MEEC) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, risk and dividends.
Institutional & Insider Ownership
90.2% of Abaxis shares are owned by institutional investors. 4.3% of Abaxis shares are owned by company insiders. Comparatively, 27.5% of Midwest Energy Emissions shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
This table compares Abaxis and Midwest Energy Emissions’ gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Midwest Energy Emissions||$27.50 million||0.91||-$2.90 million||($0.03)||-10.90|
Abaxis has higher earnings, but lower revenue than Midwest Energy Emissions.
This table compares Abaxis and Midwest Energy Emissions’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Midwest Energy Emissions||-43.83%||N/A||-70.47%|
Abaxis pays an annual dividend of $0.72 per share and has a dividend yield of 0.9%. Midwest Energy Emissions does not pay a dividend. Abaxis has increased its dividend for 3 consecutive years.
This is a breakdown of recent ratings and price targets for Abaxis and Midwest Energy Emissions, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Midwest Energy Emissions||0||0||0||0||N/A|
Abaxis presently has a consensus target price of $58.33, indicating a potential downside of 29.72%. Given Abaxis’ higher possible upside, research analysts plainly believe Abaxis is more favorable than Midwest Energy Emissions.
Abaxis beats Midwest Energy Emissions on 7 of the 9 factors compared between the two stocks.
Abaxis Company Profile
Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in human or veterinary patient care to provide rapid blood constituent measurements for clinicians worldwide. It operates in two segments, Medical Market and Veterinary Market. The company offers Piccolo chemistry analyzers with rapid blood constituent measurements for use in human patient care; and Piccolo profiles that are single-use medical reagents. It also provides VetScan VS2, a chemistry, electrolyte, immunoassay, and blood gas analyzer delivering results from a sample of whole blood, serum, or plasma; VetScan profiles, which are packaged as single-use plastic veterinary reagent discs; and VetScan HM5, VetScan HM2, VetScan HMII, and VetScan HMT hematology instruments, as well as reagent kits for veterinary applications. In addition, the company offers VetScan VSpro that assists the diagnosis and evaluation of suspected bleeding disorders, toxicity/poisoning, disseminated intravascular coagulation evaluation, hepatic disease, monitoring therapy, and disease progression states; VetScan VSpro coagulation test to evaluate prothrombin and the activated partial thromboplastin times; VetScan VSpro fibrinogen test for in-vitro determination of fibrinogen levels in equine platelet poor plasma from a citrated stabilized whole blood sample; i-STAT that delivers blood gas, electrolyte, chemistry, and hematology results; VetScan UA, a urinalysis solution; and VetScan SA, which is designed to perform urine microscopy. Further, it provides VetScan rapid tests for the detection of various diseases, as well as sells products developed through its patented Orbos discrete lyophilization process to companies for other applications. The company sells its products through direct sales force and independent distributors. Abaxis, Inc. was founded in 1989 and is headquartered in Union City, California.
Midwest Energy Emissions Company Profile
Midwest Energy Emissions Corp. operates as an environmental services and technology company. It focuses on the delivery of mercury capture technologies to coal-fired power plants in the United States, Canada, Europe, and Asia. The company is headquartered in Lewis Center, Ohio.
Receive News & Ratings for Abaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abaxis and related companies with MarketBeat.com's FREE daily email newsletter.